Based on recent headline ratings, 100% of this readership currently trusts the local media, which has an average score of 93% regionally and is currently trending positive.
Media Trust Score100%

Clinical Trial: Can ctDNA Guide Treatment in High-Risk, ER+/HER2- Breast Cancer?

… Investigator: Lazos Pusztai, MD, of Yale University in New Haven, Connecticut … Sign up to get the latest cancer therapy news in your inbox.

  • You already voted!
  • Read More